Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: A long-term follow-up study

Journal of Gynecologic Oncology

Volumn 24, Issue 2, 2013, Pages 108-113

  Ushijima, Kimio ^a   Fujiyoshi, Keizo ^a   Kawano, Kouichiro ^a   Tsuda, Naotake ^a   Nishio, Shin ^a   Eto, Hidehiro ^a   Kamura, Toshiharu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Cisplatin; Concurrent chemoradiotherapy; Daily low dose

Indexed keywords

CISPLATIN;

ABDOMINAL PAIN; ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRACHYTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EVALUATION; DIARRHEA; DRUG EFFICACY; DRUG WITHDRAWAL; ENTEROCOLITIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INTESTINE PERFORATION; KIDNEY DYSFUNCTION; LEUKOPENIA; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; UTERINE CERVIX CANCER; WEIGHT REDUCTION;

EID: 84885443684     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2013.24.2.108     Document Type: Article

References (19)

1. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161.
2. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613.
3. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143.
4. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WCJr, et al. Randomized comparison of fluo-rouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348.
5. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radio-therapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
6. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
7. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after con-comitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-786.
8. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-5812.
9. Rose PG. Chemoradiotherapy for cervical cancer. Eur J Cancer 2002;38:270-278.
10. Rose PG, Ali S, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:2804-2810.
11. Ohno T, Kato S, Tsuji H. Phase I study of weekly cisplatin plus radiotherapy for locally advanced cervical cancer. J Japan Soc Gynecol Oncol 2005;23:564-571.
12. Ikushima H, Osaki K, Furutani S, Yamashita K, Kawanaka T, Kishida Y, et al. Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin. Radiat Med 2006;24:115-121.
13. Mitsuhashi A, Uno T, Tanaka N, Suzuka K, Tate S, Yamazawa K, et al. Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma. Gynecol Oncol 2005;96:194-197.
14. Uno T, Mitsuhashi A, Isobe K, Yamamoto S, Kawakami H, Ueno N, et al. Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer 2008;18:80-84.
15. Kirwan JM, Symonds P, Green JA, Tierney J, Collingwood M, Williams CJ. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217-226.
16. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemo-therapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22:872-880.
17. Choi IJ, Cha MS, Park ES, Han MS, Choi Y, Je GH, et al. The efficacy of concurrent cisplatin and 5-flurouracil chemo-therapy and radiation therapy for locally advanced cancer of the uterine cervix. J Gynecol Oncol 2008;19:129-134.
18. Duenas-Gonzalez A, Zarba JJ, Patel F, Alcedo JC, Beslija S, Casanova L, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol 2011;29:1678-1685.
19. Wang S, Zhang DS, Pan T, Liu S, Wang MK. Efficacy of con-current chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer. Chin J Cancer 2010;29:959-963.